Compare JJSF & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JJSF | BCRX |
|---|---|---|
| Founded | 1971 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | N/A | 1994 |
| Metric | JJSF | BCRX |
|---|---|---|
| Price | $96.79 | $6.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $138.33 | $20.82 |
| AVG Volume (30 Days) | 206.0K | ★ 4.3M |
| Earning Date | 02-02-2026 | 02-23-2026 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.36 | N/A |
| Revenue | ★ $1,583,233,000.00 | $599,816,000.00 |
| Revenue This Year | $4.28 | $39.83 |
| Revenue Next Year | $2.24 | $5.47 |
| P/E Ratio | $28.90 | ★ N/A |
| Revenue Growth | 0.54 | ★ 45.38 |
| 52 Week Low | $80.67 | $6.00 |
| 52 Week High | $146.67 | $11.31 |
| Indicator | JJSF | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 62.96 | 38.23 |
| Support Level | $92.94 | $7.21 |
| Resistance Level | $98.43 | $7.27 |
| Average True Range (ATR) | 2.29 | 0.38 |
| MACD | 0.67 | -0.11 |
| Stochastic Oscillator | 82.86 | 6.10 |
J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.